BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017;32:739-749. [PMID: 28195358 DOI: 10.1002/mds.26942] [Cited by in Crossref: 313] [Cited by in F6Publishing: 281] [Article Influence: 62.6] [Reference Citation Analysis]
Number Citing Articles
1 Gwang Song J, Yu M, Lee B, Lee J, Hwang S, Na D, Wook Kim H. Analysis methods for the gut microbiome in neuropsychiatric and neurodegenerative disorders. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.02.024] [Reference Citation Analysis]
2 Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L, Betsou F, Krüger R, Thiele I; NCER-PD Consortium. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol 2020;18:62. [PMID: 32517799 DOI: 10.1186/s12915-020-00775-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 17.5] [Reference Citation Analysis]
3 Endres K, Schäfer KH. Influence of Commensal Microbiota on the Enteric Nervous System and Its Role in Neurodegenerative Diseases. J Innate Immun 2018;10:172-80. [PMID: 29742516 DOI: 10.1159/000488629] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
4 [DOI: 10.1101/397091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Peterson CT, Sharma V, Iablokov SN, Albayrak L, Khanipov K, Uchitel S, Chopra D, Mills PJ, Fofanov Y, Rodionov DA, Peterson SN. 16S rRNA gene profiling and genome reconstruction reveal community metabolic interactions and prebiotic potential of medicinal herbs used in neurodegenerative disease and as nootropics. PLoS One 2019;14:e0213869. [PMID: 30889210 DOI: 10.1371/journal.pone.0213869] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
6 van Kessel SP, El Aidy S. Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease. J Parkinsons Dis 2019;9:S359-70. [PMID: 31609701 DOI: 10.3233/JPD-191780] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433. [PMID: 33804226 DOI: 10.3390/biom11030433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study. J Clin Med 2021;10:5698. [PMID: 34884399 DOI: 10.3390/jcm10235698] [Reference Citation Analysis]
9 Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 2021;7:27. [PMID: 33692356 DOI: 10.1038/s41531-021-00156-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
10 Abbas-Egbariya H, Haberman Y, Braun T, Hadar R, Denson L, Gal-Mor O, Amir A. Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Biol 2022;23:61. [PMID: 35197084 DOI: 10.1186/s13059-022-02637-7] [Reference Citation Analysis]
11 Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson's Disease. Curr Treat Options Neurol. 2018;20:54. [PMID: 30361783 DOI: 10.1007/s11940-018-0539-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
12 Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M. Gut brain axis: an insight into microbiota role in Parkinson's disease. Metab Brain Dis 2021. [PMID: 34370175 DOI: 10.1007/s11011-021-00808-2] [Reference Citation Analysis]
13 Lin A, Zheng W, He Y, Tang W, Wei X, He R, Huang W, Su Y, Huang Y, Zhou H, Xie H. Gut microbiota in patients with Parkinson's disease in southern China. Parkinsonism & Related Disorders 2018;53:82-8. [DOI: 10.1016/j.parkreldis.2018.05.007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 22.5] [Reference Citation Analysis]
14 Zhang Y, Xu S, Qian Y, He X, Mo C, Yang X, Xiao Q. Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1α expression in PC12 cells. Brain Res 2021;1776:147749. [PMID: 34896331 DOI: 10.1016/j.brainres.2021.147749] [Reference Citation Analysis]
15 Proffitt C, Bidkhori G, Moyes D, Shoaie S. Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions. Microorganisms 2020;8:E1381. [PMID: 32916966 DOI: 10.3390/microorganisms8091381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Cardoso SM, Empadinhas N. The Microbiome-Mitochondria Dance in Prodromal Parkinson's Disease. Front Physiol 2018;9:471. [PMID: 29867531 DOI: 10.3389/fphys.2018.00471] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
17 Fleury V, Zekeridou A, Lazarevic V, Gaïa N, Giannopoulou C, Genton L, Cancela J, Girard M, Goldstein R, Bally JF, Mombelli A, Schrenzel J, Burkhard PR. Oral Dysbiosis and Inflammation in Parkinson's Disease. J Parkinsons Dis 2021;11:619-31. [PMID: 33646178 DOI: 10.3233/JPD-202459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Van Laar T, Boertien JM, Herranz AH. Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype? J Parkinsons Dis 2019;9:S371-9. [PMID: 31609702 DOI: 10.3233/JPD-191802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
19 Sun J, Li H, Jin Y, Yu J, Mao S, Su KP, Ling Z, Liu J. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 2021;91:703-15. [PMID: 33148438 DOI: 10.1016/j.bbi.2020.10.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
20 Jackson A, Forsyth CB, Shaikh M, Voigt RM, Engen PA, Ramirez V, Keshavarzian A. Diet in Parkinson's Disease: Critical Role for the Microbiome. Front Neurol 2019;10:1245. [PMID: 31920905 DOI: 10.3389/fneur.2019.01245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
21 Lister T. Nutrition and Lifestyle Interventions for Managing Parkinson's Disease: A Narrative Review. J Mov Disord 2020;13:97-104. [PMID: 32498495 DOI: 10.14802/jmd.20006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 2021;9:226. [PMID: 34784980 DOI: 10.1186/s40168-021-01107-9] [Reference Citation Analysis]
23 Duan H, Yu L, Tian F, Zhai Q, Fan L, Chen W. Gut microbiota: A target for heavy metal toxicity and a probiotic protective strategy. Sci Total Environ. 2020;742:140429. [PMID: 32629250 DOI: 10.1016/j.scitotenv.2020.140429] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
24 Cox LM, Abou-El-Hassan H, Maghzi AH, Vincentini J, Weiner HL. The sex-specific interaction of the microbiome in neurodegenerative diseases. Brain Res 2019;1724:146385. [PMID: 31419428 DOI: 10.1016/j.brainres.2019.146385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Tan AH, Chong CW, Song SL, Teh CSJ, Yap IKS, Loke MF, Tan YQ, Yong HS, Mahadeva S, Lang AE, Lim S. Altered gut microbiome and metabolome in patients with multiple system atrophy: Gut Microbiome and Metabolome In MSA. Mov Disord 2018;33:174-6. [DOI: 10.1002/mds.27203] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
26 Murciano-Brea J, Garcia-Montes M, Geuna S, Herrera-Rincon C. Gut Microbiota and Neuroplasticity. Cells 2021;10:2084. [PMID: 34440854 DOI: 10.3390/cells10082084] [Reference Citation Analysis]
27 Stockdale SR, Draper LA, O'Donovan SM, Barton W, O'Sullivan O, Volpicelli-Daley LA, Sullivan AM, O'Neill C, Hill C. Alpha-synuclein alters the faecal viromes of rats in a gut-initiated model of Parkinson's disease. Commun Biol 2021;4:1140. [PMID: 34588600 DOI: 10.1038/s42003-021-02666-1] [Reference Citation Analysis]
28 Xu R, Zhang Y, Chen S, Zeng Y, Fu X, Chen T, Luo S, Zhang X. The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential. Crit Rev Microbiol 2022;:1-26. [PMID: 35272549 DOI: 10.1080/1040841X.2022.2044286] [Reference Citation Analysis]
29 Milošević M, Arsić A, Cvetković Z, Vučić V. Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition. Front Nutr 2021;8:688086. [PMID: 34422879 DOI: 10.3389/fnut.2021.688086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K. Meta-Analysis of Gut Dysbiosis in Parkinson's Disease. Mov Disord 2020;35:1626-35. [PMID: 32557853 DOI: 10.1002/mds.28119] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 18.5] [Reference Citation Analysis]
31 Rozas NS, Tribble GD, Jeter CB. Oral Factors That Impact the Oral Microbiota in Parkinson's Disease. Microorganisms 2021;9:1616. [PMID: 34442695 DOI: 10.3390/microorganisms9081616] [Reference Citation Analysis]
32 Pusceddu MM, Del Bas JM. The role of the gut microbiota in the pathophysiology of mental and neurological disorders. Psychiatric Genetics 2020;30:87-100. [DOI: 10.1097/ypg.0000000000000255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
33 Narasimhan H, Ren CC, Deshpande S, Sylvia KE. Young at Gut-Turning Back the Clock with the Gut Microbiome. Microorganisms 2021;9:555. [PMID: 33800340 DOI: 10.3390/microorganisms9030555] [Reference Citation Analysis]
34 Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol. 2018;136:345-361. [PMID: 29797112 DOI: 10.1007/s00401-018-1856-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 19.3] [Reference Citation Analysis]
35 Sun M, Zhu Y, Zhou Z, Jia X, Xu Y, Yang Q, Cui C, Shen Y. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. Brain, Behavior, and Immunity 2018;70:48-60. [DOI: 10.1016/j.bbi.2018.02.005] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 38.3] [Reference Citation Analysis]
36 Shafer CM, Tseng A, Allard P, McEvoy MM. Strength of Cu-efflux response in E. coli coordinates metal resistance in C. elegans and contributes to the severity of environmental toxicity. J Biol Chem 2021;:101060. [PMID: 34375643 DOI: 10.1016/j.jbc.2021.101060] [Reference Citation Analysis]
37 Blesa J, Foffani G, Dehay B, Bezard E, Obeso JA. Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? Nat Rev Neurosci 2021. [PMID: 34907352 DOI: 10.1038/s41583-021-00542-9] [Reference Citation Analysis]
38 Wallen ZD. Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing. BMC Bioinformatics 2021;22:265. [PMID: 34034646 DOI: 10.1186/s12859-021-04193-6] [Reference Citation Analysis]
39 Gubert C, Kong G, Renoir T, Hannan AJ. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiol Dis 2020;134:104621. [PMID: 31628992 DOI: 10.1016/j.nbd.2019.104621] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 16.3] [Reference Citation Analysis]
40 Tan AH, Hor JW, Chong CW, Lim SY. Probiotics for Parkinson's disease: Current evidence and future directions. JGH Open 2021;5:414-9. [PMID: 33860090 DOI: 10.1002/jgh3.12450] [Reference Citation Analysis]
41 Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton AB, Barker RA, Kieburtz K, Olanow CW, Lozano A, Kordower JH, Cedarbaum JM, Brundin P, Standaert DG, Lang AE. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology 2020;94:481-94. [PMID: 32102975 DOI: 10.1212/WNL.0000000000009107] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 18.5] [Reference Citation Analysis]
42 Korf JM, Ganesh BP, Mccullough LD. Gut dysbiosis and age-related neurological diseases in females. Neurobiology of Disease 2022;168:105695. [DOI: 10.1016/j.nbd.2022.105695] [Reference Citation Analysis]
43 Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, Hirayama M. Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study. PLoS One 2017;12:e0187307. [PMID: 29091972 DOI: 10.1371/journal.pone.0187307] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 20.8] [Reference Citation Analysis]
44 Suzuki A, Ito M, Hamaguchi T, Mori H, Takeda Y, Baba R, Watanabe T, Kurokawa K, Asakawa S, Hirayama M, Ohno K. Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease. PLoS One 2018;13:e0208313. [PMID: 30586410 DOI: 10.1371/journal.pone.0208313] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
45 Callaghan B. Commentary: Microbial panaceas: does development have the answer? - reflections on Cowan, Dinan, & Cryan (2020). J Child Psychol Psychiatry 2020;61:372-5. [PMID: 31944315 DOI: 10.1111/jcpp.13192] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Lange KW, Nakamura Y, Chen N, Guo J, Kanaya S, Lange KM, Li S. Diet and medical foods in Parkinson’s disease. Food Science and Human Wellness 2019;8:83-95. [DOI: 10.1016/j.fshw.2019.03.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Zhang T, Wang T, Chen X, Zhao Z, Chen Z. Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons. Exp Ther Med 2022;23:52. [PMID: 34934429 DOI: 10.3892/etm.2021.10974] [Reference Citation Analysis]
48 Del Chierico F, Grassini P, Quagliariello A, Torti M, Russo A, Reddel S, Stocchi F. The impact of intestinal microbiota on weight loss in Parkinson's disease patients: a pilot study. Future Microbiol 2020;15:1393-404. [PMID: 33085540 DOI: 10.2217/fmb-2019-0336] [Reference Citation Analysis]
49 Minich D, Madden C, Evans MV, Ballash GA, Barr DJ, Poulsen KP, Dennis PM, Hale VL. Alterations in gut microbiota linked to provenance, sex, and chronic wasting disease in white-tailed deer (Odocoileus virginianus). Sci Rep 2021;11:13218. [PMID: 34168170 DOI: 10.1038/s41598-021-89896-9] [Reference Citation Analysis]
50 Ren T, Gao Y, Qiu Y, Jiang S, Zhang Q, Zhang J, Wang L, Zhang Y, Wang L, Nie K. Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease. Front Neurol 2020;11:137. [PMID: 32161568 DOI: 10.3389/fneur.2020.00137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
51 Shannon KM. Gut-Derived Sterile Inflammation and Parkinson's Disease. Front Neurol 2022;13:831090. [DOI: 10.3389/fneur.2022.831090] [Reference Citation Analysis]
52 Cosma-Grigorov A, Meixner H, Mrochen A, Wirtz S, Winkler J, Marxreiter F. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates. Front Neurol 2020;11:1041. [PMID: 33071933 DOI: 10.3389/fneur.2020.01041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
53 Cryan JF, O'riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. The Lancet Neurology 2020;19:179-94. [DOI: 10.1016/s1474-4422(19)30356-4] [Cited by in Crossref: 135] [Cited by in F6Publishing: 77] [Article Influence: 67.5] [Reference Citation Analysis]
54 Shobeiri P, Kalantari A, Teixeira AL, Rezaei N. Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders. Biol Sex Differ 2022;13:12. [PMID: 35337376 DOI: 10.1186/s13293-022-00422-6] [Reference Citation Analysis]
55 Kim J, Oh J, Kim Y, Kwon M, Kim J, Choi H. Association between Proton Pump Inhibitor Use and Parkinson’s Disease in a Korean Population. Pharmaceuticals 2022;15:327. [DOI: 10.3390/ph15030327] [Reference Citation Analysis]
56 Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, Bjørn Nielsen H, Gatermann SG, Przuntek H, Haghikia A. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease. Cells 2020;9:E376. [PMID: 32041265 DOI: 10.3390/cells9020376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
57 Waubant E, Pröbstel AK, Levy M, Hawkes CH, Giovannoni G, Lechner-Scott J, Tremlett H. The future of microbiome research in neuroinflammatory disorders. Mult Scler Relat Disord 2020;40:102098. [PMID: 32312515 DOI: 10.1016/j.msard.2020.102098] [Reference Citation Analysis]
58 Amorim Neto DP, Bosque BP, Pereira de Godoy JV, Rodrigues PV, Meneses DD, Tostes K, Costa Tonoli CC, Faustino de Carvalho H, González-billault C, de Castro Fonseca M. Akkermansia muciniphila induces mitochondrial calcium overload and α -synuclein aggregation in an enteroendocrine cell line. iScience 2022;25:103908. [DOI: 10.1016/j.isci.2022.103908] [Reference Citation Analysis]
59 Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson's disease: A culprit or a bystander? Prog Brain Res 2020;252:357-450. [PMID: 32247371 DOI: 10.1016/bs.pbr.2020.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
60 Boertien JM, Pereira PAB, Aho VTE, Scheperjans F. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review. J Parkinsons Dis 2019;9:S297-312. [PMID: 31498131 DOI: 10.3233/JPD-191711] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 27.5] [Reference Citation Analysis]
61 Dempsey JL, Little M, Cui JY. Gut microbiome: An intermediary to neurotoxicity. Neurotoxicology 2019;75:41-69. [PMID: 31454513 DOI: 10.1016/j.neuro.2019.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
62 Gabbianelli R, Damiani E. Epigenetics and neurodegeneration: role of early-life nutrition. The Journal of Nutritional Biochemistry 2018;57:1-13. [DOI: 10.1016/j.jnutbio.2018.01.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
63 Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK. Microbiome-microglia connections via the gut-brain axis. J Exp Med 2019;216:41-59. [PMID: 30385457 DOI: 10.1084/jem.20180794] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 22.0] [Reference Citation Analysis]
64 Liu Y, Liong M, Tsai Y. New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis. J Microbiol 2018;56:601-13. [DOI: 10.1007/s12275-018-8079-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
65 Sampson TR, Challis C, Jain N, Moiseyenko A, Ladinsky MS, Shastri GG, Thron T, Needham BD, Horvath I, Debelius JW, Janssen S, Knight R, Wittung-Stafshede P, Gradinaru V, Chapman M, Mazmanian SK. A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice. Elife 2020;9:e53111. [PMID: 32043464 DOI: 10.7554/eLife.53111] [Cited by in Crossref: 70] [Cited by in F6Publishing: 49] [Article Influence: 35.0] [Reference Citation Analysis]
66 Anis E, Xie A, Brundin L, Brundin P. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease. Trends Endocrinol Metab 2021:S1043-2760(21)00268-X. [PMID: 34949514 DOI: 10.1016/j.tem.2021.11.005] [Reference Citation Analysis]
67 Hirano A, Umeno J, Okamoto Y, Shibata H, Ogura Y, Moriyama T, Torisu T, Fujioka S, Fuyuno Y, Kawarabayasi Y, Matsumoto T, Kitazono T, Esaki M. Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis: Dysbiosis in ulcerative colitis. Journal of Gastroenterology and Hepatology 2018;33:1590-7. [DOI: 10.1111/jgh.14129] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
68 Johnson ME, Stringer A, Bobrovskaya L. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease. NeuroToxicology 2018;65:174-85. [DOI: 10.1016/j.neuro.2018.02.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
69 Cirstea MS, Yu AC, Golz E, Sundvick K, Kliger D, Radisavljevic N, Foulger LH, Mackenzie M, Huan T, Finlay BB, Appel-Cresswell S. Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease. Mov Disord 2020;35:1208-17. [PMID: 32357258 DOI: 10.1002/mds.28052] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 22.5] [Reference Citation Analysis]
70 Ma X, Asif H, Dai L, He Y, Zheng W, Wang D, Ren H, Tang J, Li C, Jin K, Li Z, Chen X. Alteration of the gut microbiome in first-episode drug-naïve and chronic medicated schizophrenia correlate with regional brain volumes. J Psychiatr Res 2020;123:136-44. [PMID: 32065949 DOI: 10.1016/j.jpsychires.2020.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
71 Solch RJ, Aigbogun JO, Voyiadjis AG, Talkington GM, Darensbourg RM, O'connell S, Pickett KM, Perez SR, Maraganore DM. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review. Journal of the Neurological Sciences 2022. [DOI: 10.1016/j.jns.2022.120166] [Reference Citation Analysis]
72 Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S, Ferri V, Cancello R, Ceccarani C, Faierman S, Pinelli G, De Bellis G, Zecca L, Cereda E, Consolandi C, Pezzoli G. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism. Mov Disord 2019;34:396-405. [PMID: 30576008 DOI: 10.1002/mds.27581] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 22.3] [Reference Citation Analysis]
73 Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation. J Neurogastroenterol Motil 2019;25:363-76. [PMID: 31327219 DOI: 10.5056/jnm19044] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
74 Yang J, Yang Y, Ishii M, Nagata M, Aw W, Obana N, Tomita M, Nomura N, Fukuda S. Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms? Microbes Environ 2020;35. [PMID: 32624527 DOI: 10.1264/jsme2.ME20037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Yang D, Xu W. Clustering on Human Microbiome Sequencing Data: A Distance-Based Unsupervised Learning Model. Microorganisms 2020;8:E1612. [PMID: 33092203 DOI: 10.3390/microorganisms8101612] [Reference Citation Analysis]
76 Baizabal-carvallo JF, Alonso-juarez M. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease. Neuroscience 2020;432:160-73. [DOI: 10.1016/j.neuroscience.2020.02.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
77 Jena R, Jain R, Muralidharan S, Yanamala VL, Zubair Z, Kantamaneni K, Jalla K, Renzu M, Alfonso M. Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson's Disease. Cureus 2021;13:e19035. [PMID: 34853754 DOI: 10.7759/cureus.19035] [Reference Citation Analysis]
78 Kubinski R, Djamen-kepaou J, Zhanabaev T, Hernandez-garcia A, Bauer S, Hildebrand F, Korcsmaros T, Karam S, Jantchou P, Kafi K, Martin RD. Benchmark of Data Processing Methods and Machine Learning Models for Gut Microbiome-Based Diagnosis of Inflammatory Bowel Disease. Front Genet 2022;13:784397. [DOI: 10.3389/fgene.2022.784397] [Reference Citation Analysis]
79 Laue HE, Coker MO, Madan JC. The Developing Microbiome From Birth to 3 Years: The Gut-Brain Axis and Neurodevelopmental Outcomes. Front Pediatr 2022;10:815885. [DOI: 10.3389/fped.2022.815885] [Reference Citation Analysis]
80 Dovrolis N, Kolios G, Spyrou GM, Maroulakou I. Computational profiling of the gut-brain axis: microflora dysbiosis insights to neurological disorders. Brief Bioinform 2019;20:825-41. [PMID: 29186317 DOI: 10.1093/bib/bbx154] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
81 Li C, Cui L, Yang Y, Miao J, Zhao X, Zhang J, Cui G, Zhang Y. Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China. Front Mol Neurosci 2019;12:171. [PMID: 31354427 DOI: 10.3389/fnmol.2019.00171] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 10.7] [Reference Citation Analysis]
82 Wang S, Jiang W, Ouyang T, Shen XY, Wang F, Qu YH, Zhang M, Luo T, Wang HQ. Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice. Sci Rep 2019;9:19575. [PMID: 31862965 DOI: 10.1038/s41598-019-56149-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
83 Qian Y, Yang X, Xu S, Huang P, Li B, Du J, He Y, Su B, Xu L, Wang L, Huang R, Chen S, Xiao Q. Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease. Brain 2020;143:2474-89. [DOI: 10.1093/brain/awaa201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
84 Peng H, Yu S, Zhang Y, Yin Y, Zhou J. Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration. Neurosci Bull . [DOI: 10.1007/s12264-022-00848-3] [Reference Citation Analysis]
85 Breen DP, Halliday GM, Lang AE. Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end? Mov Disord 2019;34:307-16. [PMID: 30653258 DOI: 10.1002/mds.27556] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 26.0] [Reference Citation Analysis]
86 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Reference Citation Analysis]
87 Kuznetsova V, Tyakht A, Akhmadishina L, Odintsova V, Klimenko N, Kostryukova E, Vakhitova M, Grigoryeva T, Malanin S, Vladimirtsev V, Nikitina R, Volok V, Osakovskiy V, Sivtseva T, Platonov F, Alexeev D, Karganova G. Gut microbiome signature of Viliuisk encephalomyelitis in Yakuts includes an increase in microbes linked to lean body mass and eating behaviour. Orphanet J Rare Dis 2020;15:327. [PMID: 33218345 DOI: 10.1186/s13023-020-01612-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Bhattarai Y, Kashyap PC. Parkinson's disease: Are gut microbes involved? Am J Physiol Gastrointest Liver Physiol 2020;319:G529-40. [PMID: 32877215 DOI: 10.1152/ajpgi.00058.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Gorecki AM, Bakeberg MC, Theunissen F, Kenna JE, Hoes ME, Pfaff AL, Akkari PA, Dunlop SA, Kõks S, Mastaglia FL, Anderton RS. Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease. Front Aging Neurosci 2020;12:603849. [PMID: 33328979 DOI: 10.3389/fnagi.2020.603849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Gallop A, Weagley J, Paracha SU, Grossberg G. The Role of The Gut Microbiome in Parkinson's Disease. J Geriatr Psychiatry Neurol 2021;34:253-62. [PMID: 34219519 DOI: 10.1177/08919887211018268] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Qian Y, Yang X, Xu S, Wu C, Qin N, Chen SD, Xiao Q. Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson's Disease. Front Aging Neurosci 2018;10:156. [PMID: 29881345 DOI: 10.3389/fnagi.2018.00156] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
92 Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG. Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease. Mov Disord 2018;33:793-804. [PMID: 29572994 DOI: 10.1002/mds.27326] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 16.8] [Reference Citation Analysis]
93 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 [DOI: 10.1101/691030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Bhuiyan P, Chen Y, Karim M, Dong H, Qian Y. Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention. Brain Res Bull 2021;172:61-78. [PMID: 33892083 DOI: 10.1016/j.brainresbull.2021.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
96 Sampson T. The impact of indigenous microbes on Parkinson's disease. Neurobiology of Disease 2020;135:104426. [DOI: 10.1016/j.nbd.2019.03.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
97 Nuzum ND, Loughman A, Szymlek-Gay EA, Hendy A, Teo WP, Macpherson H. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review. Neurosci Biobehav Rev 2020;112:227-41. [PMID: 32032654 DOI: 10.1016/j.neubiorev.2020.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
98 Heintz-Buschart A, Pandey U, Wicke T, Sixel-Döring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 2018;33:88-98. [PMID: 28843021 DOI: 10.1002/mds.27105] [Cited by in Crossref: 190] [Cited by in F6Publishing: 167] [Article Influence: 38.0] [Reference Citation Analysis]
99 Maiuolo J, Gliozzi M, Musolino V, Carresi C, Scarano F, Nucera S, Scicchitano M, Oppedisano F, Bosco F, Ruga S, Zito MC, Macri R, Palma E, Muscoli C, Mollace V. The Contribution of Gut Microbiota-Brain Axis in the Development of Brain Disorders. Front Neurosci 2021;15:616883. [PMID: 33833660 DOI: 10.3389/fnins.2021.616883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
100 Shannon K, Vanden Berghe P. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell Tissue Res 2018;373:313-26. [PMID: 29936550 DOI: 10.1007/s00441-018-2856-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
101 Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease. JAMA Neurol 2018;75:939-46. [PMID: 29710331 DOI: 10.1001/jamaneurol.2018.0605] [Cited by in Crossref: 124] [Cited by in F6Publishing: 118] [Article Influence: 41.3] [Reference Citation Analysis]
102 Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev 2022;:e0033820. [PMID: 34985325 DOI: 10.1128/CMR.00338-20] [Reference Citation Analysis]
103 Shin C, Lim Y, Lim H, Ahn T. Plasma Short‐Chain Fatty Acids in Patients With Parkinson's Disease. Mov Disord 2020;35:1021-7. [DOI: 10.1002/mds.28016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
104 Brown EG, Goldman SM. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond. Neurotherapeutics 2020;17:1406-17. [PMID: 33034846 DOI: 10.1007/s13311-020-00942-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
105 Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G, Dunlop SA, Mastaglia FL, Akkari PA, Koengten F, Anderton RS. Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model. Front Neurosci 2019;13:839. [PMID: 31440136 DOI: 10.3389/fnins.2019.00839] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
106 Fang P, Kazmi SA, Jameson KG, Hsiao EY. The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell Host Microbe 2020;28:201-22. [PMID: 32791113 DOI: 10.1016/j.chom.2020.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
107 Mao L, Zhang Y, Tian J, Sang M, Zhang G, Zhou Y, Wang P. Cross-Sectional Study on the Gut Microbiome of Parkinson's Disease Patients in Central China. Front Microbiol 2021;12:728479. [PMID: 34650532 DOI: 10.3389/fmicb.2021.728479] [Reference Citation Analysis]
108 Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota-gut-brain axis. Acta Pharm Sin B 2021;11:2859-79. [PMID: 34589401 DOI: 10.1016/j.apsb.2021.03.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Kakoty V, K C S, Dubey SK, Yang CH, Kesharwani P, Taliyan R. The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy. Neurosci Lett 2021;753:135865. [PMID: 33812929 DOI: 10.1016/j.neulet.2021.135865] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Perez-Pardo P, Hartog M, Garssen J, Kraneveld AD. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease. Curr Behav Neurosci Rep 2017;4:361-8. [PMID: 29201595 DOI: 10.1007/s40473-017-0129-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
111 Tyler Patterson T, Grandhi R. Gut Microbiota and Neurologic Diseases and Injuries. Adv Exp Med Biol 2020;1238:73-91. [PMID: 32323181 DOI: 10.1007/978-981-15-2385-4_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
112 Sharma P, Agrawal A. Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders over the last decade. Neurosurg Rev 2021. [PMID: 33904013 DOI: 10.1007/s10143-021-01516-2] [Reference Citation Analysis]
113 Radisavljevic N, Cirstea M, Brett Finlay B. Bottoms up: the role of gut microbiota in brain health. Environ Microbiol 2018. [PMID: 30556271 DOI: 10.1111/1462-2920.14506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
114 Weis S, Schwiertz A, Unger MM, Becker A, Faßbender K, Ratering S, Kohl M, Schnell S, Schäfer KH, Egert M. Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota. NPJ Parkinsons Dis 2019;5:28. [PMID: 31815177 DOI: 10.1038/s41531-019-0100-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
115 Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, Shannon KM, Garssen J, Kraneveld AD, Keshavarzian A. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut. 2019;68:829-843. [PMID: 30554160 DOI: 10.1136/gutjnl-2018-316844] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 26.5] [Reference Citation Analysis]
116 Uyar GÖ, Yildiran H. A nutritional approach to microbiota in Parkinson's disease. Biosci Microbiota Food Health 2019;38:115-27. [PMID: 31763115 DOI: 10.12938/bmfh.19-002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
117 Wang S, Li N, Zou H, Wu M. Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson’s disease. Neuroscience Letters 2019;696:93-8. [DOI: 10.1016/j.neulet.2018.12.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
118 Castillo-Álvarez F, Marzo-Sola ME. Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed) 2019:S0213-4853(19)30082-9. [PMID: 31340904 DOI: 10.1016/j.nrl.2019.03.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
119 Mirza A, Forbes JD, Zhu F, Bernstein CN, Van Domselaar G, Graham M, Waubant E, Tremlett H. The multiple sclerosis gut microbiota: A systematic review. Mult Scler Relat Disord 2020;37:101427. [PMID: 32172998 DOI: 10.1016/j.msard.2019.101427] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
120 Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG. Does Parkinson's disease start in the gut? Acta Neuropathol 2018;135:1-12. [PMID: 29039141 DOI: 10.1007/s00401-017-1777-8] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 19.6] [Reference Citation Analysis]
121 Dwyer Z, Chaiquin M, Landrigan J, Ayoub K, Shail P, Rocha J, Childers CL, Storey KB, Philpott DJ, Sun H, Hayley S. The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson's disease. J Neuroinflammation 2021;18:20. [PMID: 33422110 DOI: 10.1186/s12974-020-02062-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
122 Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis 2020;6:11. [PMID: 32566740 DOI: 10.1038/s41531-020-0112-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
123 Wang W, Hu L, Chang S, Ma L, Li X, Yang Z, Du C, Qu X, Zhang C, Wang S. Total body irradiation-induced colon damage is prevented by nitrate-mediated suppression of oxidative stress and homeostasis of the gut microbiome. Nitric Oxide 2020;102:1-11. [PMID: 32470598 DOI: 10.1016/j.niox.2020.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Tilocca B, Pieroni L, Soggiu A, Britti D, Bonizzi L, Roncada P, Greco V. Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization. Int J Mol Sci 2020;21:E4045. [PMID: 32516966 DOI: 10.3390/ijms21114045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
125 Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Hilbert F, Lindqvist R, Nauta M, Peixe L, Ru G, Simmons M, Skandamis P, Suffredini E, Cocconcelli PS, Fernández Escámez PS, Maradona MP, Querol A, Suarez JE, Sundh I, Vlak J, Barizzone F, Hempen M, Herman L; EFSA Panel on Biological Hazards (BIOHAZ). Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 12: suitability of taxonomic units notified to EFSA until March 2020. EFSA J 2020;18:e06174. [PMID: 32760463 DOI: 10.2903/j.efsa.2020.6174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
126 Galluzzo P, Capri FC, Vecchioni L, Realmuto S, Scalisi L, Cottone S, Nuzzo D, Alduina R. Comparison of the Intestinal Microbiome of Italian Patients with Multiple Sclerosis and Their Household Relatives. Life (Basel) 2021;11:620. [PMID: 34206853 DOI: 10.3390/life11070620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673-85. [PMID: 32737460 DOI: 10.1038/s41575-020-0339-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
128 Yan Y, Ren S, Duan Y, Lu C, Niu Y, Wang Z, Inglis B, Ji W, Zheng Y, Si W. Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease. NPJ Biofilms Microbiomes 2021;7:69. [PMID: 34475403 DOI: 10.1038/s41522-021-00242-3] [Reference Citation Analysis]
129 Shen L. Gut, oral and nasal microbiota and Parkinson's disease. Microb Cell Fact 2020;19:50. [PMID: 32103766 DOI: 10.1186/s12934-020-01313-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
130 Zheng W, He R, Yan Z, Huang Y, Huang W, Cai Z, Su Y, Liu S, Deng Y, Wang Q, Xie H. Regulation of immune-driven pathogenesis in Parkinson's disease by gut microbiota. Brain Behav Immun 2020;87:890-7. [PMID: 31931152 DOI: 10.1016/j.bbi.2020.01.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
131 Zhang J, Culp ML, Craver JG, Darley-Usmar V. Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease. J Neurochem 2018;144:691-709. [PMID: 29341130 DOI: 10.1111/jnc.14308] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
132 Scheperjans F, Derkinderen P, Borghammer P. The Gut and Parkinson's Disease: Hype or Hope? J Parkinsons Dis 2018;8:S31-9. [PMID: 30584161 DOI: 10.3233/JPD-181477] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 12.3] [Reference Citation Analysis]
133 Mulak A, Koszewicz M, Panek-Jeziorna M, Koziorowska-Gawron E, Budrewicz S. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease. Front Neurosci 2019;13:992. [PMID: 31611762 DOI: 10.3389/fnins.2019.00992] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
134 Smith NA, Germundson DL, Gao P, Hur J, Floden AM, Nagamoto-Combs K. Anxiety-like behavior and intestinal microbiota changes as strain-and sex-dependent sequelae of mild food allergy in mouse models of cow's milk allergy. Brain Behav Immun 2021;95:122-41. [PMID: 33705867 DOI: 10.1016/j.bbi.2021.03.002] [Reference Citation Analysis]
135 Abe K, Hirayama M, Ohno K, Shimamura T. A latent allocation model for the analysis of microbial composition and disease. BMC Bioinformatics 2018;19:519. [PMID: 30598099 DOI: 10.1186/s12859-018-2530-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
136 Jeon H, Bae CH, Lee Y, Kim HY, Kim S. Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon. Brain Behav Immun 2021;94:410-23. [PMID: 33662500 DOI: 10.1016/j.bbi.2021.02.028] [Reference Citation Analysis]
137 Lymberopoulos E, Gentili GI, Alomari M, Sharma N. Topological Data Analysis Highlights Novel Geographical Signatures of the Human Gut Microbiome. Front Artif Intell 2021;4:680564. [PMID: 34490420 DOI: 10.3389/frai.2021.680564] [Reference Citation Analysis]
138 Wu S, Hammarstedt-Nordenvall L, Jangard M, Cheng L, Radu SA, Angelidou P, Zha Y, Hamsten M, Engstrand L, Du J, Ternhag A. Tonsillar Microbiota: a Cross-Sectional Study of Patients with Chronic Tonsillitis or Tonsillar Hypertrophy. mSystems 2021;6:e01302-20. [PMID: 33688019 DOI: 10.1128/mSystems.01302-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Pietrucci D, Teofani A, Unida V, Cerroni R, Biocca S, Stefani A, Desideri A. Can Gut Microbiota Be a Good Predictor for Parkinson's Disease? A Machine Learning Approach. Brain Sci 2020;10:E242. [PMID: 32325848 DOI: 10.3390/brainsci10040242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
140 Liu X, Liu S, Tang Y, Pu Z, Xiao H, Gao J, Yin Q, Jia Y, Bai Q. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease. Neurochem Res 2021;46:1514-39. [PMID: 33719004 DOI: 10.1007/s11064-021-03293-2] [Reference Citation Analysis]
141 Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. EBioMedicine 2019;44:691-707. [PMID: 31221587 DOI: 10.1016/j.ebiom.2019.05.064] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 25.3] [Reference Citation Analysis]
142 Jung TD, Jung PS, Raveendran L, Farbod Y, Dvorkin-Gheva A, Sakic B, Surette MG, Szechtman H. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole. Behav Pharmacol 2018;29:211-24. [PMID: 29194070 DOI: 10.1097/FBP.0000000000000363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
143 Rutsch A, Kantsjö JB, Ronchi F. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Front Immunol 2020;11:604179. [PMID: 33362788 DOI: 10.3389/fimmu.2020.604179] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
144 Vascellari S, Melis M, Cossu G, Melis M, Serra A, Palmas V, Perra D, Oppo V, Fiorini M, Cusano R, Morelli M, Manzin A, Barbarossa IT. Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study. Int J Biol Macromol 2020;165:665-74. [PMID: 32946938 DOI: 10.1016/j.ijbiomac.2020.09.056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
145 Chapelet G, Leclair-Visonneau L, Clairembault T, Neunlist M, Derkinderen P. Can the gut be the missing piece in uncovering PD pathogenesis? Parkinsonism Relat Disord 2019;59:26-31. [PMID: 30448099 DOI: 10.1016/j.parkreldis.2018.11.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
146 [DOI: 10.1101/2020.08.10.20171397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Wang S, Yong H, He XD. Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus. World J Diabetes 2021; 12(7): 1070-1080 [PMID: 34326955 DOI: 10.4239/wjd.v12.i7.1070] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Bridges KN, Zhang Y, Curran TE, Magnuson JT, Venables BJ, Durrer KE, Allen MS, Roberts AP. Alterations to the Intestinal Microbiome and Metabolome of Pimephales promelas and Mus musculus Following Exposure to Dietary Methylmercury. Environ Sci Technol 2018;52:8774-84. [DOI: 10.1021/acs.est.8b01150] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
149 Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L. Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease. Eur J Neurol 2019;26:490-6. [PMID: 30347489 DOI: 10.1111/ene.13844] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
150 Chung KA, Pfeiffer RF. Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 2021;31:77-99. [PMID: 33247399 DOI: 10.1007/s10286-020-00745-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
151 Kenna JE, Chua EG, Bakeberg M, Tay A, McGregor S, Gorecki A, Horne M, Marshall B, Mastaglia FL, Anderton RS. Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson's Disease Cohort. Front Neurosci 2021;15:756951. [PMID: 34776854 DOI: 10.3389/fnins.2021.756951] [Reference Citation Analysis]
152 Hsieh TH, Kuo CW, Hsieh KH, Shieh MJ, Peng CW, Chen YC, Chang YL, Huang YZ, Chen CC, Chang PK, Chen KY, Chen HY. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease. Brain Sci 2020;10:E206. [PMID: 32244769 DOI: 10.3390/brainsci10040206] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
153 Scheperjans F. The prodromal microbiome: The Prodromal Microbiome. Mov Disord 2018;33:5-7. [DOI: 10.1002/mds.27197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
154 Wampach L, Heintz-Buschart A, Hogan A, Muller EEL, Narayanasamy S, Laczny CC, Hugerth LW, Bindl L, Bottu J, Andersson AF, de Beaufort C, Wilmes P. Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life. Front Microbiol 2017;8:738. [PMID: 28512451 DOI: 10.3389/fmicb.2017.00738] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 22.2] [Reference Citation Analysis]
155 Bedarf JR, Hildebrand F, Goeser F, Bork P, Wüllner U. Das Darmmikrobiom bei der Parkinson-Krankheit. Nervenarzt 2019;90:160-6. [DOI: 10.1007/s00115-018-0601-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
156 Melis M, Vascellari S, Santoru ML, Oppo V, Fabbri M, Sarchioto M, Murgia D, Zibetti M, Lopiano L, Serra A, Palmas V, Pisanu S, Perra D, Madau V, Cusano R, Uva P, Mereu A, Contu P, Morelli M, Atzori L, Melis M, Manzin A, Cossu G. Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel. Eur J Neurol 2021;28:1198-209. [PMID: 33185912 DOI: 10.1111/ene.14644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
157 Chung SJ, Rim JH, Ji D, Lee S, Yoo HS, Jung JH, Baik K, Choi Y, Ye BS, Sohn YH, Yun M, Lee SG, Lee PH. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease. Nutrition 2021;83:111090. [PMID: 33418492 DOI: 10.1016/j.nut.2020.111090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Karunaratne TB, Okereke C, Seamon M, Purohit S, Wakade C, Sharma A. Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson's Disease. Nutrients 2020;13:E28. [PMID: 33374784 DOI: 10.3390/nu13010028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Tansey MG, Romero-Ramos M. Immune system responses in Parkinson's disease: Early and dynamic. Eur J Neurosci 2019;49:364-83. [PMID: 30474172 DOI: 10.1111/ejn.14290] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
160 Vidal-Martinez G, Chin B, Camarillo C, Herrera GV, Yang B, Sarosiek I, Perez RG. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. J Parkinsons Dis 2020;10:185-92. [PMID: 31561385 DOI: 10.3233/JPD-191693] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
161 Ojeda J, Ávila A, Vidal PM. Gut Microbiota Interaction with the Central Nervous System throughout Life. J Clin Med 2021;10:1299. [PMID: 33801153 DOI: 10.3390/jcm10061299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
162 Fu S, Shih L, Wu P, Hsieh Y, Lee C, Lin S, Wang H. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data. Front Cell Infect Microbiol 2022;12:871710. [DOI: 10.3389/fcimb.2022.871710] [Reference Citation Analysis]
163 Spichak S, Bastiaanssen TFS, Berding K, Vlckova K, Clarke G, Dinan TG, Cryan JF. Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease. Neurosci Biobehav Rev 2021;125:698-761. [PMID: 33675857 DOI: 10.1016/j.neubiorev.2021.02.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
164 Li J, Lu H, Wu H, Huang S, Chen L, Gui Q, Zhou W, Yang Y, Wu Y, Zhang H, Zhang Q, Yang Y. Periodontitis in elderly patients with type 2 diabetes mellitus: impact on gut microbiota and systemic inflammation. Aging (Albany NY) 2020;12:25956-80. [PMID: 33234730 DOI: 10.18632/aging.202174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
165 Wright ML, Fournier C, Houser MC, Tansey M, Glass J, Hertzberg VS. Potential Role of the Gut Microbiome in ALS: A Systematic Review. Biol Res Nurs 2018;20:513-21. [PMID: 29925252 DOI: 10.1177/1099800418784202] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
166 Hutz MH, Rieder CR. The future of pharmacogenetics in Parkinson's disease treatment. Pharmacogenomics 2018;19:171-4. [PMID: 29191064 DOI: 10.2217/pgs-2017-0180] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
167 Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, Song SL, Tan JY, Ang BH, Tan YQ, Kho MT, Bowman J, Mahadeva S, Yong HS, Lang AE. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics. Ann Neurol 2021;89:546-59. [PMID: 33274480 DOI: 10.1002/ana.25982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
168 Yang T, Chakraborty S, Mandal J, Mei X, Joe B. Microbiota and Metabolites as Factors Influencing Blood Pressure Regulation. Compr Physiol 2021;11:1731-57. [PMID: 33792901 DOI: 10.1002/cphy.c200009] [Reference Citation Analysis]
169 Miller AL, Bessho S, Grando K, Tükel Ç. Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases. Front Immunol 2021;12:638867. [PMID: 33717189 DOI: 10.3389/fimmu.2021.638867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
170 Tsao SP, Nurrahma BA, Kumar R, Wu CH, Yeh TH, Chiu CC, Lee YP, Liao YC, Huang CH, Yeh YT, Huang HY. Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson's Disease Rats. Antioxidants (Basel) 2021;10:1823. [PMID: 34829694 DOI: 10.3390/antiox10111823] [Reference Citation Analysis]
171 Jeyakumar T, Beauchemin N, Gros P. Impact of the Microbiome on the Human Genome. Trends Parasitol 2019;35:809-21. [PMID: 31451407 DOI: 10.1016/j.pt.2019.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Wang Y, Nan X, Zhao Y, Wang Y, Jiang L, Xiong B. Ruminal Degradation of Rumen-Protected Glucose Influences the Ruminal Microbiota and Metabolites in Early-Lactation Dairy Cows. Appl Environ Microbiol 2021;87:e01908-20. [PMID: 33097510 DOI: 10.1128/AEM.01908-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
173 Takahashi K, Nishiwaki H, Ito M, Iwaoka K, Takahashi K, Suzuki Y, Taguchi K, Yamahara K, Tsuboi Y, Kashihara K, Hirayama M, Ohno K, Maeda T. Altered gut microbiota in Parkinson's disease patients with motor complications. Parkinsonism Relat Disord 2021;95:11-7. [PMID: 34954497 DOI: 10.1016/j.parkreldis.2021.12.012] [Reference Citation Analysis]
174 Zheng H, Shi C, Luo H, Fan L, Yang Z, Hu X, Zhang Z, Zhang S, Hu Z, Fan Y, Yang J, Mao C, Xu Y. α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role? Neuroscientist 2021;27:367-87. [PMID: 32729773 DOI: 10.1177/1073858420943180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
175 Brown EG, Tanner CM, Goldman SM. The Microbiome in Neurodegenerative Disease. Curr Geri Rep 2018;7:81-91. [DOI: 10.1007/s13670-018-0240-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
176 Cryan JF, O'riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-smith CM, Lyte JM, Martin JA, Molinero-perez A, Moloney G, Morelli E, Morillas E, O'connor R, Cruz-pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-silva AP, Wallace-fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain Axis. Physiological Reviews 2019;99:1877-2013. [DOI: 10.1152/physrev.00018.2018] [Cited by in Crossref: 551] [Cited by in F6Publishing: 492] [Article Influence: 183.7] [Reference Citation Analysis]
177 Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, Li XF, Gao BL. Association of Parkinson's Disease With Microbes and Microbiological Therapy. Front Cell Infect Microbiol 2021;11:619354. [PMID: 33763383 DOI: 10.3389/fcimb.2021.619354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
178 Chen C, Zhang B, Hu A, Li H, Liu J, Zhang F. Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. Journal of Ethnopharmacology 2020;247:112299. [DOI: 10.1016/j.jep.2019.112299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
179 Hopfner F, Künstner A, Müller SH, Künzel S, Zeuner KE, Margraf NG, Deuschl G, Baines JF, Kuhlenbäumer G. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 2017;1667:41-5. [PMID: 28506555 DOI: 10.1016/j.brainres.2017.04.019] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 27.4] [Reference Citation Analysis]
180 Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wüllner U. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. Genome Med 2017;9:39. [PMID: 28449715 DOI: 10.1186/s13073-017-0428-y] [Cited by in Crossref: 192] [Cited by in F6Publishing: 194] [Article Influence: 38.4] [Reference Citation Analysis]
181 Han MN, Finkelstein DI, Mcquade RM, Diwakarla S. Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. JPM 2022;12:144. [DOI: 10.3390/jpm12020144] [Reference Citation Analysis]
182 Zhu X, Li B, Lou P, Dai T, Chen Y, Zhuge A, Yuan Y, Li L. The Relationship Between the Gut Microbiome and Neurodegenerative Diseases. Neurosci Bull 2021. [PMID: 34216356 DOI: 10.1007/s12264-021-00730-8] [Reference Citation Analysis]
183 Gopar-Cuevas Y, Duarte-Jurado AP, Diaz-Perez RN, Saucedo-Cardenas O, Loera-Arias MJ, Montes-de-Oca-Luna R, Rodriguez-Rocha H, Garcia-Garcia A. Pursuing Multiple Biomarkers for Early Idiopathic Parkinson's Disease Diagnosis. Mol Neurobiol 2021. [PMID: 34350555 DOI: 10.1007/s12035-021-02500-z] [Reference Citation Analysis]
184 Haindl R, Engel J, Kulozik U. Establishment of an In Vitro System of the Human Intestinal Microbiota: Effect of Cultivation Conditions and Influence of Three Donor Stool Samples. Microorganisms 2021;9:1049. [PMID: 34068085 DOI: 10.3390/microorganisms9051049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Gotkine M, Kviatcovsky D, Elinav E. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect. Gut Microbes 2020;11:1833-41. [PMID: 32501768 DOI: 10.1080/19490976.2020.1767464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
186 Bullich C, Keshavarzian A, Garssen J, Kraneveld A, Perez-Pardo P. Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis. Mov Disord Clin Pract 2019;6:639-51. [PMID: 31745471 DOI: 10.1002/mdc3.12840] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
187 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
188 Waters JL, Ley RE. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biol 2019;17:83. [PMID: 31660948 DOI: 10.1186/s12915-019-0699-4] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 29.7] [Reference Citation Analysis]
189 Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N. Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence? Nutrients 2019;11:E1896. [PMID: 31416163 DOI: 10.3390/nu11081896] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
190 Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 2021;11:625913. [PMID: 33816335 DOI: 10.3389/fcimb.2021.625913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
191 Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB, Biocca S, Stefani A, Desideri A. Dysbiosis of gut microbiota in a selected population of Parkinson's patients. Parkinsonism Relat Disord 2019;65:124-30. [PMID: 31174953 DOI: 10.1016/j.parkreldis.2019.06.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 18.0] [Reference Citation Analysis]
192 Haindl R, Schick S, Kulozik U. Influence of Cultivation pH on Composition, Diversity, and Metabolic Production in an In Vitro Human Intestinal Microbiota. Fermentation 2021;7:156. [DOI: 10.3390/fermentation7030156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 White H. Gastrointestinal Disorders and the Nervous System. Continuum (Minneap Minn) 2020;26:577-90. [PMID: 32487897 DOI: 10.1212/CON.0000000000000871] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
194 Volpicelli-Daley L, Brundin P. Editorial: Pathogenic templating proteins in Neurodegenerative Disease. Neurobiol Dis 2018;109:175-7. [PMID: 29249413 DOI: 10.1016/j.nbd.2017.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
195 Fields CT, Sampson TR, Bruce-Keller AJ, Kiraly DD, Hsiao EY, de Vries GJ. Defining Dysbiosis in Disorders of Movement and Motivation. J Neurosci 2018;38:9414-22. [PMID: 30381433 DOI: 10.1523/JNEUROSCI.1672-18.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
196 Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM. Parkinson's disease and the gastrointestinal microbiome. J Neurol 2020;267:2507-23. [PMID: 31041582 DOI: 10.1007/s00415-019-09320-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
197 Ling Z, Liu X, Cheng Y, Yan X, Wu S. Gut microbiota and aging. Crit Rev Food Sci Nutr 2020;:1-56. [PMID: 33377391 DOI: 10.1080/10408398.2020.1867054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Madore C, Yin Z, Leibowitz J, Butovsky O. Microglia, Lifestyle Stress, and Neurodegeneration. Immunity 2020;52:222-40. [PMID: 31924476 DOI: 10.1016/j.immuni.2019.12.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 26.5] [Reference Citation Analysis]
199 Ji T, Huang H, Liu J, Peng T, Zhou X, Tan Q, Yuan J, Hua H, Ding S, Liu H. Leveraging sequence-based faecal microbial community survey data to identify alterations in gut microbiota among patients with Parkinson's disease. Eur J Neurosci 2021;53:687-96. [PMID: 32865266 DOI: 10.1111/ejn.14952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
200 A. Flameling I, T. Rijkers G. Fecal Microbiota Transplants as a Treatment Option for Parkinson’s Disease. In: Evrensel A, Önen Ünsalver B, editors. Gut Microbiota - Brain Axis. IntechOpen; 2018. [DOI: 10.5772/intechopen.78666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
201 Verma H, Phian S, Lakra P, Kaur J, Subudhi S, Lal R, Rawat CD. Human Gut Microbiota and Mental Health: Advancements and Challenges in Microbe-Based Therapeutic Interventions. Indian J Microbiol 2020;60:405-19. [PMID: 33087991 DOI: 10.1007/s12088-020-00898-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
202 Dong M, Li L, Chen M, Kusalik A, Xu W. Predictive analysis methods for human microbiome data with application to Parkinson's disease. PLoS One 2020;15:e0237779. [PMID: 32834004 DOI: 10.1371/journal.pone.0237779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
203 Wang LK, Yang XD, Zhou D, Cheng T, Zhang X, Wu HY. Prenatal Isoflurane Exposure Induces Developmental Neurotoxicity in Rats: the Role of Gut Microbiota. Neurotox Res 2022. [PMID: 35294710 DOI: 10.1007/s12640-022-00487-6] [Reference Citation Analysis]
204 Hill AE, Wade-Martins R, Burnet PWJ. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease? Front Neurosci 2021;15:708587. [PMID: 34512244 DOI: 10.3389/fnins.2021.708587] [Reference Citation Analysis]
205 Li Y, Wang X, Wang Y, Wang F, Xia S, Zhao J. Struvite-supported biochar composite effectively lowers Cu bio-availability and the abundance of antibiotic-resistance genes in soil. Science of The Total Environment 2020;724:138294. [DOI: 10.1016/j.scitotenv.2020.138294] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
206 Ray S, Narayanan A, Giske CG, Neogi U, Sönnerborg A, Nowak P. Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine. ACS Infect Dis 2021;7:1104-15. [PMID: 33346662 DOI: 10.1021/acsinfecdis.0c00536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
207 Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. PLoS Pathog 2017;13:e1006654. [PMID: 29267402 DOI: 10.1371/journal.ppat.1006654] [Cited by in Crossref: 135] [Cited by in F6Publishing: 113] [Article Influence: 27.0] [Reference Citation Analysis]
208 Yang J, Ning HC, Zhang Q, Yue JQ, Cao XY, Li JY, Liu L, Zhao HP, Zhao HX. Effects of Bacillus subtilis BS-Z15 on Intestinal Microbiota Structure and Body Weight Gain in Mice. Probiotics Antimicrob Proteins 2022. [PMID: 35029788 DOI: 10.1007/s12602-021-09897-y] [Reference Citation Analysis]
209 Hirayama M, Nishiwaki H, Hamaguchi T, Ito M, Ueyama J, Maeda T, Kashihara K, Tsuboi Y, Ohno K. Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate. PLoS One 2021;16:e0260451. [PMID: 34813629 DOI: 10.1371/journal.pone.0260451] [Reference Citation Analysis]
210 Wallen ZD, Stone WJ, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Exploring human-genome gut-microbiome interaction in Parkinson's disease. NPJ Parkinsons Dis 2021;7:74. [PMID: 34408160 DOI: 10.1038/s41531-021-00218-2] [Reference Citation Analysis]
211 Qian Y, Yang X, Xu S, Wu C, Song Y, Qin N, Chen SD, Xiao Q. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease. Brain Behav Immun. 2018;70:194-202. [PMID: 29501802 DOI: 10.1016/j.bbi.2018.02.016] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 31.5] [Reference Citation Analysis]
212 Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 2019;364:eaau6323. [PMID: 31196984 DOI: 10.1126/science.aau6323] [Cited by in Crossref: 159] [Cited by in F6Publishing: 133] [Article Influence: 53.0] [Reference Citation Analysis]
213 Haikal C, Chen QQ, Li JY. Microbiome changes: an indicator of Parkinson's disease? Transl Neurodegener 2019;8:38. [PMID: 31890161 DOI: 10.1186/s40035-019-0175-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
214 Payami H. The emerging science of precision medicine and pharmacogenomics for Parkinson's disease. Mov Disord 2017;32:1139-46. [PMID: 28686320 DOI: 10.1002/mds.27099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
215 Gorecki AM, Anyaegbu CC, Anderton RS. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut. Transl Neurodegener 2021;10:47. [PMID: 34814947 DOI: 10.1186/s40035-021-00271-0] [Reference Citation Analysis]
216 Quigley EMM. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep 2017;17:94. [PMID: 29039142 DOI: 10.1007/s11910-017-0802-6] [Cited by in Crossref: 205] [Cited by in F6Publishing: 185] [Article Influence: 41.0] [Reference Citation Analysis]
217 Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-zamora A, Mai V, Vedam-mai V. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front Aging Neurosci 2022;13:782082. [DOI: 10.3389/fnagi.2021.782082] [Reference Citation Analysis]
218 Guo T, Chen L. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights. Eur J Inflamm 2022;20:1721727X2210837. [DOI: 10.1177/1721727x221083763] [Reference Citation Analysis]
219 Zanon A, Pramstaller PP, Hicks AA, Pichler I. Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance. Parkinsons Dis 2018;2018:8684906. [PMID: 29707191 DOI: 10.1155/2018/8684906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
220 Hertzberg VS, Singh H, Fournier CN, Moustafa A, Polak M, Kuelbs CA, Torralba MG, Tansey MG, Nelson KE, Glass JD. Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls. Amyotroph Lateral Scler Frontotemporal Degener 2021;:1-9. [PMID: 33818222 DOI: 10.1080/21678421.2021.1904994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
221 Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, Ye S, Ye K, Wei D, Song Z, Chen D, Liu J. Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP/PS1 transgenic mice. Transl Psychiatry 2019;9:189. [PMID: 31383855 DOI: 10.1038/s41398-019-0525-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 24.7] [Reference Citation Analysis]
222 Plassais J, Gbikpi-Benissan G, Figarol M, Scheperjans F, Gorochov G, Derkinderen P, Cervino ACL. Gut microbiome alpha-diversity is not a marker of Parkinson's disease and multiple sclerosis. Brain Commun 2021;3:fcab113. [PMID: 34704023 DOI: 10.1093/braincomms/fcab113] [Reference Citation Analysis]
223 Flores Saiffe Farías A, Mendizabal AP, Morales JA. An Ontology Systems Approach on Human Brain Expression and Metaproteomics. Front Microbiol 2018;9:406. [PMID: 29568289 DOI: 10.3389/fmicb.2018.00406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
224 Wang W, Zhu G, Wang Y, Li W, Yi S, Wang K, Fan L, Tang J, Chen R. Multi-Omics Integration in Mice With Parkinson’s Disease and the Intervention Effect of Cyanidin-3-O-Glucoside. Front Aging Neurosci 2022;14:877078. [DOI: 10.3389/fnagi.2022.877078] [Reference Citation Analysis]
225 Lee JA, Chico TJA, Renshaw SA. The triune of intestinal microbiome, genetics and inflammatory status and its impact on the healing of lower gastrointestinal anastomoses. FEBS J. 2018;285:1212-1225. [PMID: 29193751 DOI: 10.1111/febs.14346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
226 Kaur H, Bose C, Mande SS. Tryptophan Metabolism by Gut Microbiome and Gut-Brain-Axis: An in silico Analysis. Front Neurosci 2019;13:1365. [PMID: 31920519 DOI: 10.3389/fnins.2019.01365] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
227 Zheng SY, Li HX, Xu RC, Miao WT, Dai MY, Ding ST, Liu HD. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 2021;69:101347. [PMID: 33905953 DOI: 10.1016/j.arr.2021.101347] [Reference Citation Analysis]
228 Fang X. Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis. Metab Brain Dis 2018;33:1031-43. [PMID: 29681010 DOI: 10.1007/s11011-018-0239-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
229 Turna J, Grosman Kaplan K, Anglin R, Patterson B, Soreni N, Bercik P, Surette MG, Van Ameringen M. The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study. Acta Psychiatr Scand 2020;142:337-47. [PMID: 32307692 DOI: 10.1111/acps.13175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
230 Martin BD, Witten D, Willis AD. MODELING MICROBIAL ABUNDANCES AND DYSBIOSIS WITH BETA-BINOMIAL REGRESSION. Ann Appl Stat 2020;14:94-115. [PMID: 32983313 DOI: 10.1214/19-aoas1283] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 21.0] [Reference Citation Analysis]
231 Leclercq S, Schwarz M, Delzenne NM, Stärkel P, de Timary P. Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms. Transl Psychiatry 2021;11:503. [PMID: 34599147 DOI: 10.1038/s41398-021-01610-5] [Reference Citation Analysis]
232 Gong X, Liu X, Chen C, Lin J, Li A, Guo K, An D, Zhou D, Hong Z. Alteration of Gut Microbiota in Patients With Epilepsy and the Potential Index as a Biomarker. Front Microbiol 2020;11:517797. [PMID: 33042045 DOI: 10.3389/fmicb.2020.517797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
233 Yang X, Qian Y, Xu S, Song Y, Xiao Q. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease. Front Aging Neurosci 2017;9:441. [PMID: 29358918 DOI: 10.3389/fnagi.2017.00441] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
234 Wu G, Jiang Z, Pu Y, Chen S, Wang T, Wang Y, Xu X, Wang S, Jin M, Yao Y, Liu Y, Ke S, Liu S. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients. BMC Neurol 2022;22:13. [PMID: 34996385 DOI: 10.1186/s12883-021-02544-7] [Reference Citation Analysis]
235 Bai W, Dong M, Li L, Feng C, Xu W. Randomized quantile residuals for diagnosing zero-inflated generalized linear mixed models with applications to microbiome count data. BMC Bioinformatics 2021;22:564. [PMID: 34823466 DOI: 10.1186/s12859-021-04371-6] [Reference Citation Analysis]
236 Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A. Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women. Mov Disord 2018;33:1492-6. [PMID: 30218460 DOI: 10.1002/mds.109] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
237 Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC. What is the Healthy Gut Microbiota Composition? Microorganisms. 2019;7. [PMID: 30634578 DOI: 10.3390/microorganisms7010014] [Cited by in Crossref: 514] [Cited by in F6Publishing: 425] [Article Influence: 171.3] [Reference Citation Analysis]
238 Weinberg RP, Koledova VV, Subramaniam A, Schneider K, Artamonova A, Sambanthamurthi R, Hayes KC, Sinskey AJ, Rha C. Palm Fruit Bioactives augment expression of Tyrosine Hydroxylase in the Nile Grass Rat basal ganglia and alter the colonic microbiome. Sci Rep 2019;9:18625. [PMID: 31819070 DOI: 10.1038/s41598-019-54461-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
239 S A, K G, A AM. Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19. J Biomol Struct Dyn 2021;:1-17. [PMID: 34699326 DOI: 10.1080/07391102.2021.1994875] [Reference Citation Analysis]
240 Vascellari S, Manzin A. Parkinson's Disease: A Prionopathy? Int J Mol Sci 2021;22:8022. [PMID: 34360787 DOI: 10.3390/ijms22158022] [Reference Citation Analysis]
241 Minamisawa M, Suzumura T, Bose S, Taniai T, Kawai G, Suzuki K, Yamaguchi A, Yamanaka S. Effect of Yuzu (Citrus junos) Seed Limonoids and Spermine on Intestinal Microbiota and Hypothalamic Tissue in the Sandhoff Disease Mouse Model. Med Sci (Basel) 2021;9:17. [PMID: 33799734 DOI: 10.3390/medsci9010017] [Reference Citation Analysis]
242 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
243 Song S, Liu J, Zhang F, Hong JS. Norepinephrine depleting toxin DSP-4 and LPS alter gut microbiota and induce neurotoxicity in α-synuclein mutant mice. Sci Rep 2020;10:15054. [PMID: 32929122 DOI: 10.1038/s41598-020-72202-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
244 Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H, Gao J, Jia Y, Bai Q. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease. Neurochem Res 2018;43:1986-99. [PMID: 30171422 DOI: 10.1007/s11064-018-2620-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
245 Ji F, Zhang D, Shao Y, Yu X, Liu X, Shan D, Wang Z. Changes in the diversity and composition of gut microbiota in pigeon squabs infected with Trichomonas gallinae. Sci Rep 2020;10:19978. [PMID: 33203893 DOI: 10.1038/s41598-020-76821-9] [Reference Citation Analysis]
246 Bell JS, Spencer JI, Yates RL, Yee SA, Jacobs BM, Deluca GC. Invited Review: From nose to gut – the role of the microbiome in neurological disease. Neuropathol Appl Neurobiol 2019;45:195-215. [DOI: 10.1111/nan.12520] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
247 Unger MM, Becker A, Keller A, Schäfer KH, Schwiertz A, Oertel WH. [The role of the gut microbiome in idiopathic Parkinson's disease]. Nervenarzt 2020;91:1085-95. [PMID: 33025073 DOI: 10.1007/s00115-020-01011-x] [Reference Citation Analysis]
248 Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS. Innate and adaptive immune responses in Parkinson's disease. Prog Brain Res 2020;252:169-216. [PMID: 32247364 DOI: 10.1016/bs.pbr.2019.10.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
249 Deidda G, Biazzo M. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Front Neurosci 2021;15:753915. [PMID: 34712115 DOI: 10.3389/fnins.2021.753915] [Reference Citation Analysis]
250 Dănău A, Dumitrescu L, Lefter A, Tulbă D, Popescu BO. Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease. Int J Mol Sci 2021;22:11663. [PMID: 34769091 DOI: 10.3390/ijms222111663] [Reference Citation Analysis]
251 Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci 2018;1420:5-25. [PMID: 28768369 DOI: 10.1111/nyas.13416] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 22.0] [Reference Citation Analysis]
252 Sun MF, Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Ageing Res Rev 2018;45:53-61. [PMID: 29705121 DOI: 10.1016/j.arr.2018.04.004] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 21.8] [Reference Citation Analysis]
253 Sarkar A, Yoo JY, Valeria Ozorio Dutra S, Morgan KH, Groer M. The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases. J Clin Med 2021;10:459. [PMID: 33504109 DOI: 10.3390/jcm10030459] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
254 Lubomski M, Xu X, Holmes AJ, Muller S, Yang JYH, Davis RL, Sue CM. Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease. Front Aging Neurosci 2022;14:881872. [DOI: 10.3389/fnagi.2022.881872] [Reference Citation Analysis]
255 Li Z, Lu G, Li Z, Wu B, Luo E, Qiu X, Guo J, Xia Z, Zheng C, Su Q, Zeng Y, Chan WY, Su X, Cai Q, Xu Y, Chen Y, Wang M, Poon WS, Luo X. Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson's Disease. Front Immunol 2021;12:632482. [PMID: 34276644 DOI: 10.3389/fimmu.2021.632482] [Reference Citation Analysis]
256 Becker A, Faßbender K, Oertel WH, Unger MM. A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 2019;60:43-5. [PMID: 30292735 DOI: 10.1016/j.parkreldis.2018.09.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
257 van Kessel SP, Bullock A, van Dijk G, El Aidy S. Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats. mSystems 2022;:e0119121. [PMID: 35076270 DOI: 10.1128/msystems.01191-21] [Reference Citation Analysis]
258 Ilie OD, Ciobica A, McKenna J, Doroftei B, Mavroudis I. Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxid Med Cell Longev 2020;2020:4518023. [PMID: 32089768 DOI: 10.1155/2020/4518023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
259 Chen TJ, Feng Y, Liu T, Wu TT, Chen YJ, Li X, Li Q, Wu YC. Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease. Front Neurosci 2020;14:549037. [PMID: 33381005 DOI: 10.3389/fnins.2020.549037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
260 Xicoy H, Wieringa B, Martens GJM. The Role of Lipids in Parkinson's Disease. Cells 2019;8:E27. [PMID: 30621069 DOI: 10.3390/cells8010027] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 21.0] [Reference Citation Analysis]
261 Baert F, Matthys C, Maselyne J, Van Poucke C, Van Coillie E, Bergmans B, Vlaemynck G. Parkinson's disease patients' short chain fatty acids production capacity after in vitro fecal fiber fermentation. NPJ Parkinsons Dis 2021;7:72. [PMID: 34389734 DOI: 10.1038/s41531-021-00215-5] [Reference Citation Analysis]
262 Padhi P, Worth C, Zenitsky G, Jin H, Sambamurti K, Anantharam V, Kanthasamy A, Kanthasamy AG. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders. Front Neurosci 2022;16:836605. [DOI: 10.3389/fnins.2022.836605] [Reference Citation Analysis]
263 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
264 Ryu G, Kim H, Koh A. Approaching precision medicine by tailoring the microbiota. Mamm Genome 2021;32:206-22. [PMID: 33646347 DOI: 10.1007/s00335-021-09859-3] [Reference Citation Analysis]
265 Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP. Is Gut Dysbiosis an Epicenter of Parkinson's Disease? Neurochem Res 2021;46:425-38. [PMID: 33400024 DOI: 10.1007/s11064-020-03187-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Sun BL, Li WW, Wang J, Xu YL, Sun HL, Tian DY, Wang YJ, Yao XQ. Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model. J Alzheimers Dis 2019;70:399-412. [PMID: 31177213 DOI: 10.3233/JAD-181220] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
267 Brandau L, Weis S, Weyland M, Berger FK, Schnell S, Schäfer K, Egert M. RNA-based stable isotope probing provides no indication for rapid α-synuclein assimilation by murine gut bacteria. Access Microbiology 2022;4. [DOI: 10.1099/acmi.0.000345] [Reference Citation Analysis]
268 Yuan X, Tian Y, Liu C, Zhang Z. Environmental factors in Parkinson's disease: New insights into the molecular mechanisms. Toxicol Lett 2021;356:1-10. [PMID: 34864130 DOI: 10.1016/j.toxlet.2021.12.003] [Reference Citation Analysis]
269 Karagöz MA, Nalbantoglu OU. Taxonomic classification of metagenomic sequences from Relative Abundance Index profiles using deep learning. Biomedical Signal Processing and Control 2021;67:102539. [DOI: 10.1016/j.bspc.2021.102539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
270 Grün D, Zimmer VC, Kauffmann J, Spiegel J, Dillmann U, Schwiertz A, Faßbender K, Fousse M, Unger MM. Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease. Parkinsonism & Related Disorders 2020;70:20-2. [DOI: 10.1016/j.parkreldis.2019.11.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
271 Pascale A, Marchesi N, Govoni S, Barbieri A. Targeting the microbiota in pharmacology of psychiatric disorders. Pharmacol Res 2020;157:104856. [PMID: 32389857 DOI: 10.1016/j.phrs.2020.104856] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
272 Herrick MK, Tansey MG. Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease? NPJ Parkinsons Dis 2021;7:26. [PMID: 33750819 DOI: 10.1038/s41531-021-00170-1] [Reference Citation Analysis]
273 Cilia R, Piatti M, Cereda E, Bolliri C, Caronni S, Ferri V, Cassani E, Bonvegna S, Ferrarese C, Zecchinelli AL, Barichella M, Pezzoli G. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients. J Parkinsons Dis 2021;11:159-70. [PMID: 33337387 DOI: 10.3233/JPD-202297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
274 Liao JF, Cheng YF, You ST, Kuo WC, Huang CW, Chiou JJ, Hsu CC, Hsieh-Li HM, Wang S, Tsai YC. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Brain Behav Immun 2020;90:26-46. [PMID: 32739365 DOI: 10.1016/j.bbi.2020.07.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
275 Zhang F, Yue L, Fang X, Wang G, Li C, Sun X, Jia X, Yang J, Song J, Zhang Y, Guo C, Ma G, Sang M, Chen F, Wang P. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. Parkinsonism Relat Disord 2020;81:84-8. [PMID: 33099131 DOI: 10.1016/j.parkreldis.2020.10.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
276 Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, Miggiano GAD, Gasbarrini A, Mele MC. Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. Nutrients 2019;11:E2393. [PMID: 31591348 DOI: 10.3390/nu11102393] [Cited by in Crossref: 111] [Cited by in F6Publishing: 97] [Article Influence: 37.0] [Reference Citation Analysis]
277 Fang X, Li FJ, Hong DJ. Potential Role of Akkermansia muciniphila in Parkinson's Disease and Other Neurological/Autoimmune Diseases. Curr Med Sci 2021;41:1172-7. [PMID: 34893951 DOI: 10.1007/s11596-021-2464-5] [Reference Citation Analysis]
278 Kenna JE, Bakeberg MC, Gorecki AM, Chin Yen Tay A, Winter S, Mastaglia FL, Anderton RS. Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case-Control Study in an Australian Cohort. Mov Disord Clin Pract 2021;8:245-53. [PMID: 33553495 DOI: 10.1002/mdc3.13134] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
279 Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Front Neurol 2019;10:1155. [PMID: 31781020 DOI: 10.3389/fneur.2019.01155] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
280 Rousseaux MWC, Shulman JM, Jankovic J. Progress toward an integrated understanding of Parkinson's disease. F1000Res 2017;6:1121. [PMID: 28751973 DOI: 10.12688/f1000research.11820.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
281 Tetel MJ, de Vries GJ, Melcangi RC, Panzica G, O'Mahony SM. Steroids, stress and the gut microbiome-brain axis. J Neuroendocrinol 2018;30. [PMID: 29024170 DOI: 10.1111/jne.12548] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 18.3] [Reference Citation Analysis]
282 Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson's disease: A unifying theory. Ageing Res Rev 2021;70:101396. [PMID: 34171417 DOI: 10.1016/j.arr.2021.101396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
283 Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, van Loveren H, Ackerl R, Knutsen HK; EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J 2021;19:e06780. [PMID: 34484452 DOI: 10.2903/j.efsa.2021.6780] [Reference Citation Analysis]
284 Zhu Y, Huan F, Wang J, Xie X, Yu G, Wang X, Jiang L, Gao R, Xiao H, Ding H, Wang J. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis. ACS Chem Neurosci 2020;11:3366-76. [PMID: 32926778 DOI: 10.1021/acschemneuro.0c00475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
285 Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM. α-Synuclein in Parkinson's disease: causal or bystander? J Neural Transm (Vienna) 2019;126:815-40. [PMID: 31240402 DOI: 10.1007/s00702-019-02025-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 13.7] [Reference Citation Analysis]
286 Harsanyiova J, Buday T, Kralova Trancikova A. Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis. Front Neurosci 2020;14:626. [PMID: 32625058 DOI: 10.3389/fnins.2020.00626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
287 Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis. Front Aging Neurosci 2021;13:636545. [PMID: 33643026 DOI: 10.3389/fnagi.2021.636545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
288 Jeon S, Kim H, Kim J, Seol D, Jo J, Choi Y, Cho S, Kim H. Positive Effect of Lactobacillus acidophilus EG004 on Cognitive Ability of Healthy Mice by Fecal Microbiome Analysis Using Full-Length 16S-23S rRNA Metagenome Sequencing. Microbiol Spectr 2022;:e0181521. [PMID: 35019699 DOI: 10.1128/spectrum.01815-21] [Reference Citation Analysis]
289 Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, Zengin G, Mathew B, Shah MA, Arora S. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease. Curr Neuropharmacol 2021;19:233-47. [PMID: 32504503 DOI: 10.2174/1570159X18666200606233050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
290 Murcia-Garzón J, Méndez-Tenorio A. Promiscuous Domains in Eukaryotes and HAT Proteins in FUNGI Have Followed Different Evolutionary Paths. J Mol Evol 2022. [PMID: 35084521 DOI: 10.1007/s00239-021-10046-w] [Reference Citation Analysis]
291 Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease. Front Cell Infect Microbiol 2021;11:615075. [PMID: 33968794 DOI: 10.3389/fcimb.2021.615075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
292 Reed X, Schumacher-Schuh A, Hu J, Bandres-Ciga S. Advancing Personalized Medicine in Common Forms of Parkinson's Disease through Genetics: Current Therapeutics and the Future of Individualized Management. J Pers Med 2021;11:169. [PMID: 33804504 DOI: 10.3390/jpm11030169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Huang X, Fan X, Ying J, Chen S. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med. 2019;17:67. [PMID: 30819194 DOI: 10.1186/s12967-019-1810-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 16.0] [Reference Citation Analysis]
294 Brás IC, Dominguez-Meijide A, Gerhardt E, Koss D, Lázaro DF, Santos PI, Vasili E, Xylaki M, Outeiro TF. Synucleinopathies: Where we are and where we need to go. J Neurochem 2020;153:433-54. [PMID: 31957016 DOI: 10.1111/jnc.14965] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
295 Müller T, Möhr J. Long-term management of Parkinson’s disease using levodopa combinations. Expert Opinion on Pharmacotherapy 2018;19:1003-11. [DOI: 10.1080/14656566.2018.1484108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
296 Kang Y, Kang X, Zhang H, Liu Q, Yang H, Fan W. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy. ASN Neuro 2021;13:17590914211016217. [PMID: 34053243 DOI: 10.1177/17590914211016217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
297 Dumitrescu L, Marta D, Dănău A, Lefter A, Tulbă D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease. Front Neurosci 2021;15:689723. [PMID: 34220443 DOI: 10.3389/fnins.2021.689723] [Reference Citation Analysis]
298 Gerhardt S, Mohajeri MH. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases. Nutrients 2018;10:E708. [PMID: 29857583 DOI: 10.3390/nu10060708] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 25.0] [Reference Citation Analysis]
299 Baert F, Matthys C, Mellaerts R, Lemaître D, Vlaemynck G, Foulon V. Dietary Intake of Parkinson's Disease Patients. Front Nutr 2020;7:105. [PMID: 32793623 DOI: 10.3389/fnut.2020.00105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Cheng D, Song J, Xie M, Song D. The bidirectional relationship between host physiology and microbiota and health benefits of probiotics: A review. Trends in Food Science & Technology 2019;91:426-35. [DOI: 10.1016/j.tifs.2019.07.044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
301 Ternák G, Kuti D, Kovács KJ. Dysbiosis in Parkinson's disease might be triggered by certain antibiotics. Med Hypotheses 2020;137:109564. [PMID: 31954994 DOI: 10.1016/j.mehy.2020.109564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
302 Vascellari S, Melis M, Palmas V, Pisanu S, Serra A, Perra D, Santoru ML, Oppo V, Cusano R, Uva P, Atzori L, Morelli M, Cossu G, Manzin A. Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes. Biomolecules 2021;11:144. [PMID: 33499229 DOI: 10.3390/biom11020144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
303 Chen Z, Maqbool J, Sajid F, Hussain G, Sun T. Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases. Microb Pathog 2021;150:104675. [PMID: 33352217 DOI: 10.1016/j.micpath.2020.104675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
304 Peterson CT. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. J Evid Based Integr Med 2020;25:2515690X20957225. [PMID: 33092396 DOI: 10.1177/2515690X20957225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
305 Cantu-Jungles TM, Rasmussen HE, Hamaker BR. Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease. Front Neurol 2019;10:663. [PMID: 31281287 DOI: 10.3389/fneur.2019.00663] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
306 Islam MR, Hassan YI, Das Q, Lepp D, Hernandez M, Godfrey DV, Orban S, Ross K, Delaquis P, Diarra MS. Dietary organic cranberry pomace influences multiple blood biochemical parameters and cecal microbiota in pasture-raised broiler chickens. Journal of Functional Foods 2020;72:104053. [DOI: 10.1016/j.jff.2020.104053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
307 Mukherjee K, Huddleston JP, Narindoshvili T, Nemmara VV, Raushel FM. Functional Characterization of the ycjQRS Gene Cluster from Escherichia coli: A Novel Pathway for the Transformation of d-Gulosides to d-Glucosides. Biochemistry 2019;58:1388-99. [PMID: 30742415 DOI: 10.1021/acs.biochem.8b01278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
308 Vamanu E, Rai SN. The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis. Diseases 2021;9:45. [PMID: 34201465 DOI: 10.3390/diseases9030045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
309 Tirassa P, Schirinzi T, Raspa M, Ralli M, Greco A, Polimeni A, Possenti R, Mercuri NB, Severini C. What substance P might tell us about the prognosis and mechanism of Parkinson's disease? Neurosci Biobehav Rev 2021;131:899-911. [PMID: 34653503 DOI: 10.1016/j.neubiorev.2021.10.008] [Reference Citation Analysis]
310 Marizzoni M, Provasi S, Cattaneo A, Frisoni GB. Microbiota and neurodegenerative diseases. Curr Opin Neurol 2017;30:630-8. [PMID: 28906270 DOI: 10.1097/WCO.0000000000000496] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
311 Elfil M, Kamel S, Kandil M, Koo BB, Schaefer SM. Implications of the Gut Microbiome in Parkinson's Disease. Mov Disord 2020;35:921-33. [DOI: 10.1002/mds.28004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
312 Palacios N, Hannoun A, Flahive J, Ward D, Goostrey K, Deb A, Smith KM. Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease. Front Neurol 2021;12:574529. [PMID: 33746867 DOI: 10.3389/fneur.2021.574529] [Reference Citation Analysis]
313 Bianchi VE, Herrera PF, Laura R. Effect of nutrition on neurodegenerative diseases. A systematic review. Nutr Neurosci 2019;:1-25. [PMID: 31684843 DOI: 10.1080/1028415X.2019.1681088] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
314 Mihaila D, Donegan J, Barns S, LaRocca D, Du Q, Zheng D, Vidal M, Neville C, Uhlig R, Middleton FA. The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function. PLoS One 2019;14:e0218252. [PMID: 31247001 DOI: 10.1371/journal.pone.0218252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
315 Mirzaei R, Bouzari B, Hosseini-Fard SR, Mazaheri M, Ahmadyousefi Y, Abdi M, Jalalifar S, Karimitabar Z, Teimoori A, Keyvani H, Zamani F, Yousefimashouf R, Karampoor S. Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomed Pharmacother 2021;139:111661. [PMID: 34243604 DOI: 10.1016/j.biopha.2021.111661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
316 van Kessel SP, El Aidy S. Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease. Front Neurol 2019;10:1087. [PMID: 31681153 DOI: 10.3389/fneur.2019.01087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
317 Mulak A. A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease. Mov Disord 2018;33:398-401. [PMID: 29436731 DOI: 10.1002/mds.27304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
318 Abe K, Hirayama M, Ohno K, Shimamura T. ENIGMA: an enterotype-like unigram mixture model for microbial association analysis. BMC Genomics 2019;20:191. [PMID: 30967109 DOI: 10.1186/s12864-019-5476-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
319 Cirstea M, Radisavljevic N, Finlay BB. Good Bug, Bad Bug: Breaking through Microbial Stereotypes. Cell Host Microbe. 2018;23:10-13. [PMID: 29324224 DOI: 10.1016/j.chom.2017.12.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
320 Hang Z, Lei T, Zeng Z, Cai S, Bi W, Du H. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer. Biomed Pharmacother 2022;145:112343. [PMID: 34864312 DOI: 10.1016/j.biopha.2021.112343] [Reference Citation Analysis]
321 Brudek T. Inflammatory Bowel Diseases and Parkinson's Disease. J Parkinsons Dis 2019;9:S331-44. [PMID: 31609699 DOI: 10.3233/JPD-191729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
322 Holingue C, Budavari AC, Rodriguez KM, Zisman CR, Windheim G, Fallin MD. Sex Differences in the Gut-Brain Axis: Implications for Mental Health. Curr Psychiatry Rep 2020;22:83. [PMID: 33216233 DOI: 10.1007/s11920-020-01202-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
323 Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67:1716-1725. [PMID: 29934437 DOI: 10.1136/gutjnl-2018-316723] [Cited by in Crossref: 447] [Cited by in F6Publishing: 405] [Article Influence: 111.8] [Reference Citation Analysis]
324 Bykova N, Litovka N, Popenko A, Musienko S. Pet-Human Gut Microbiome Host Classifier Using Data from Different Studies. Microorganisms 2020;8:E1591. [PMID: 33076521 DOI: 10.3390/microorganisms8101591] [Reference Citation Analysis]
325 Lubomski M, Xu X, Holmes AJ, Yang JYH, Sue CM, Davis RL. The impact of device-assisted therapies on the gut microbiome in Parkinson's disease. J Neurol 2021. [PMID: 34128115 DOI: 10.1007/s00415-021-10657-9] [Reference Citation Analysis]
326 Toh TS, Chong CW, Lim SY, Bowman J, Cirstea M, Lin CH, Chen CC, Appel-Cresswell S, Finlay BB, Tan AH. Gut microbiome in Parkinson's disease: New insights from meta-analysis. Parkinsonism Relat Disord 2021;94:1-9. [PMID: 34844021 DOI: 10.1016/j.parkreldis.2021.11.017] [Reference Citation Analysis]
327 Miraglia F, Colla E. Microbiome, Parkinson's Disease and Molecular Mimicry. Cells 2019;8:E222. [PMID: 30866550 DOI: 10.3390/cells8030222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
328 Vascellari S, Palmas V, Melis M, Pisanu S, Cusano R, Uva P, Perra D, Madau V, Sarchioto M, Oppo V, Simola N, Morelli M, Santoru ML, Atzori L, Melis M, Cossu G, Manzin A. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease. mSystems 2020;5:e00561-20. [PMID: 32934117 DOI: 10.1128/mSystems.00561-20] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
329 Shaik L, Kashyap R, Thotamgari SR, Singh R, Khanna S. Gut-Brain Axis and its Neuro-Psychiatric Effects: A Narrative Review. Cureus 2020;12:e11131. [PMID: 33240722 DOI: 10.7759/cureus.11131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Di Gioia D, Bozzi Cionci N, Baffoni L, Amoruso A, Pane M, Mogna L, Gaggìa F, Lucenti MA, Bersano E, Cantello R, De Marchi F, Mazzini L. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med 2020;18:153. [PMID: 32546239 DOI: 10.1186/s12916-020-01607-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
331 Li F, Wang P, Chen Z, Sui X, Xie X, Zhang J. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease. Neuroscience Letters 2019;707:134297. [DOI: 10.1016/j.neulet.2019.134297] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
332 Barrett MJ, Sargent L, Nawaz H, Weintraub D, Price ET, Willis AW. Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe? Mov Disord Clin Pract 2021;8:1181-8. [PMID: 34765683 DOI: 10.1002/mdc3.13347] [Reference Citation Analysis]
333 Nielsen SD, Pearson NM, Seidler K. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport. Brain Res 2021;1769:147609. [PMID: 34371014 DOI: 10.1016/j.brainres.2021.147609] [Reference Citation Analysis]
334 O'Donovan SM, Crowley EK, Brown JR, O'Sullivan O, O'Leary OF, Timmons S, Nolan YM, Clarke DJ, Hyland NP, Joyce SA, Sullivan AM, O'Neill C. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome. Neurogastroenterol Motil 2020;32:e13726. [PMID: 31576631 DOI: 10.1111/nmo.13726] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
335 Nishiwaki H, Hamaguchi T, Ito M, Ishida T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder. mSystems 2020;5:e00797-20. [PMID: 33293403 DOI: 10.1128/mSystems.00797-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
336 Barnett JA, Bandy ML, Gibson DL. Is the Use of Glyphosate in Modern Agriculture Resulting in Increased Neuropsychiatric Conditions Through Modulation of the Gut-brain-microbiome Axis? Front Nutr 2022;9:827384. [DOI: 10.3389/fnut.2022.827384] [Reference Citation Analysis]
337 Kujawska M, Jodynis-Liebert J. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut? Int J Mol Sci 2018;19:E3573. [PMID: 30424585 DOI: 10.3390/ijms19113573] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
338 De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson's Disease: An Environmental Agenda. J Parkinsons Dis 2021. [PMID: 34719434 DOI: 10.3233/JPD-212922] [Reference Citation Analysis]
339 Jin M, Li J, Liu F, Lyu N, Wang K, Wang L, Liang S, Tao H, Zhu B, Alkasir R. Analysis of the Gut Microflora in Patients With Parkinson's Disease. Front Neurosci 2019;13:1184. [PMID: 31824239 DOI: 10.3389/fnins.2019.01184] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
340 Nixon AM, Meadowcroft MD, Neely EB, Snyder AM, Purnell CJ, Wright J, Lamendella R, Nandar W, Huang X, Connor JR. HFE Genotype Restricts the Response to Paraquat in a Mouse Model of Neurotoxicity. J Neurochem 2018;145:299-311. [DOI: 10.1111/jnc.14299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
341 Guzmán-Sáenz A, Haiminen N, Basu S, Parida L. Signal enrichment with strain-level resolution in metagenomes using topological data analysis. BMC Genomics 2019;20:194. [PMID: 30967115 DOI: 10.1186/s12864-019-5490-y] [Reference Citation Analysis]
342 Ning J, Huang SY, Chen SD, Zhang YR, Huang YY, Yu JT. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study. J Alzheimers Dis 2022. [PMID: 35275534 DOI: 10.3233/JAD-215411] [Reference Citation Analysis]